CMP : 319


Shilpa Medicare Ltd. produces and exports active pharmaceutical ingredients, fine chemicals, intermediates, herbal products, and specialty chemical products.

Shilpa Medicare is a decent bet in mid cap pharma space. NPM has significantly improved in FY10 which is a good sign. Revenue growth has been good in the last 5 years. Its currently trading at P/E of 15 which looks good to buy. It also looks good on the chart. Buy and accumulate on dips of 10%.